Or Refractory Classic Hodgkin Lymphoma

Top drugs studied for this disease

CLINICAL_TRIALS trial_result · 2021-12-17
Clinical Trial Update: PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating PD-1 inhibitor with decitabine followed by autologous stem cell transplant as second-line therapy for relapsed or r…